Literature DB >> 7513605

Reduction of tumor necrosis factor production by splenocytes from v-Ha-ras oncogene-bearing mice.

G J Chen1, L L Colombo, M C Lopez, R R Watson.   

Abstract

Mice containing the activated v-Ha-ras oncogene driven by the mouse mammary tumor virus promoter/enhancer produced less tumor necrosis factor (TNF) than genetically identical animals without it. Inbred Oncomice containing the v-Ha-ras oncogene and inbred FVB mice without it were grown for 6 months. Splenocytes were isolated and stimulated in vitro to produce tumor necrosis factor (TNF) and gamma-interferon (IFN). TNF production by cells from Oncomice was significantly decreased compared to cells from FBV mice. There was a tendency for decrease, but no significant difference was seen on IFN release. These observations suggest that the oncogene may play a role in the immune system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7513605      PMCID: PMC7125649          DOI: 10.1016/0304-3835(93)90236-3

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  14 in total

1.  Characterization of the in vitro and in vivo species preference of human and murine tumor necrosis factor-alpha.

Authors:  S M Kramer; B B Aggarwal; T E Eessalu; S M McCabe; B L Ferraiolo; I S Figari; M A Palladino
Journal:  Cancer Res       Date:  1988-02-15       Impact factor: 12.701

Review 2.  Tumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities.

Authors:  C Grunfeld; M A Palladino
Journal:  Adv Intern Med       Date:  1990

Review 3.  Genetics of cancer predisposition.

Authors:  M F Hansen; W K Cavenee
Journal:  Cancer Res       Date:  1987-11-01       Impact factor: 12.701

4.  Modulation of tumor necrosis factor and gamma interferon production by cocaine and morphine in aging mice infected with LP-BM5, a murine retrovirus.

Authors:  G J Chen; R R Watson
Journal:  J Leukoc Biol       Date:  1991-10       Impact factor: 4.962

5.  Thy-1 as a negative growth regulator in ras-transformed mouse fibroblasts.

Authors:  Y Sugimoto; Y Ikawa; H Nakauchi
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

6.  Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes.

Authors:  T A Stewart; P K Pattengale; P Leder
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

7.  Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity.

Authors:  M A Palladino; M R Shalaby; S M Kramer; B L Ferraiolo; R A Baughman; A B Deleo; D Crase; B Marafino; B B Aggarwal; I S Figari
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

8.  Proliferation, senescence, and neoplastic progression of beta cells in hyperplasic pancreatic islets.

Authors:  G Teitelman; S Alpert; D Hanahan
Journal:  Cell       Date:  1988-01-15       Impact factor: 41.582

Review 9.  Transgenic mice as probes into complex systems.

Authors:  D Hanahan
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

10.  Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor.

Authors:  A A Creasey; M T Reynolds; W Laird
Journal:  Cancer Res       Date:  1986-11       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.